Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Novogen - 26 Year Stock Price History | KZIA

Historical daily share price chart and data for Novogen since 1999 adjusted for splits and dividends. The latest closing stock price for Novogen as of November 14, 2025 is 6.27.
  • The all-time high Novogen stock closing price was 2027.71 on December 05, 2003.
  • The Novogen 52-week high stock price is 150.25, which is 2296.3% above the current share price.
  • The Novogen 52-week low stock price is 2.86, which is 54.4% below the current share price.
  • The average Novogen stock price for the last 52 weeks is 23.23.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Novogen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 6.4477 8.7250 11.4300 3.0900 6.2700 -29.15%
2024 18.2804 22.5000 62.0000 8.8500 8.8500 -59.73%
2023 47.4183 37.4200 77.2500 19.2500 21.9750 -28.52%
2022 202.0169 428.0000 432.5000 25.0850 30.7450 -92.70%
2021 509.6467 449.0000 735.5000 367.5000 421.0000 -2.55%
2020 257.1375 224.5000 673.5000 128.0000 432.0000 99.08%
2019 160.5473 122.5000 370.0000 113.4900 217.0000 78.60%
2018 198.5802 167.5000 312.5000 110.1300 121.5000 -23.58%
2017 202.3080 292.0000 358.0000 120.0000 158.9950 -45.74%
2016 393.9526 410.0000 554.0000 292.0000 293.0000 -29.90%
2015 710.2748 430.3270 1838.8500 416.3810 418.0000 0.87%
2014 690.0546 858.6610 1071.8300 326.7300 414.3890 -51.63%
2013 852.8697 452.2460 1802.9900 366.5750 856.6690 89.97%
2012 191.0032 178.4330 664.4190 97.3270 450.9480 1633.16%
2011 55.9906 36.3225 140.8000 25.9539 26.0188 -21.37%
2010 79.0278 162.2120 189.4630 26.7455 33.0912 -79.27%
2009 161.6479 174.5400 319.8820 83.0526 159.6160 -1.21%
2008 341.1098 349.0800 564.4970 126.5250 161.5630 -54.64%
2007 578.6825 671.5570 817.5470 327.6680 356.2170 -45.97%
2006 787.2036 1184.1500 1194.5300 569.4670 659.2350 -44.08%
2005 1257.9619 1430.7100 1472.8800 1132.8900 1178.9500 -17.71%
2004 1329.5064 1767.4600 1907.6100 979.7590 1432.6500 -19.12%
2003 1035.7955 703.3510 2027.7100 489.8790 1771.3500 185.53%
2002 419.9227 486.6350 620.3630 209.5780 620.3630 18.77%
2001 382.3614 510.9670 742.1190 128.4720 522.3220 2.22%
2000 724.1258 648.8470 924.6080 510.9670 510.9670 -21.25%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.010B $0.000B
Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The company's lead program is GDC-0084, a small molecule inhibitor of the PI3K / AKT / mTOR pathway, which is being developed to treat glioblastoma multiforme, the primary and most aggressive form of brain cancer. Kazia Therapeutics Limited, formerly known as Novogen Limited, is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $276.335B 19.50
Amgen (AMGN) United States $181.328B 15.40
Gilead Sciences (GILD) United States $155.110B 15.26
Vertex Pharmaceuticals (VRTX) United States $110.913B 28.55
GSK (GSK) United Kingdom $95.795B 10.65
Bristol Myers Squibb (BMY) United States $94.968B 7.11
Regeneron Pharmaceuticals (REGN) United States $72.886B 18.91
Alnylam Pharmaceuticals (ALNY) United States $59.340B 1952.87
CSL (CSLLY) Australia $57.093B 0.00
Argenex SE (ARGX) Netherlands $55.903B 69.42
Insmed (INSM) United States $41.209B 0.00
Novozymes (NVZMY) Denmark $30.168B 0.00
BioNTech SE (BNTX) Germany $24.789B 0.00
Biogen (BIIB) United States $24.580B 10.01
Royalty Pharma (RPRX) United States $22.605B 8.66
Incyte (INCY) United States $20.447B 19.58
Genmab (GNMSF) Denmark $20.087B 14.74
Genmab (GMAB) Denmark $19.429B 14.62
Illumina (ILMN) United States $18.438B 27.68
Roivant Sciences (ROIV) United Kingdom $13.856B 0.00
Revolution Medicines (RVMD) United States $13.097B 0.00
Exact Sciences (EXAS) United States $12.700B 352.79
Ascendis Pharma (ASND) Denmark $12.610B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Guardant Health (GH) United States $11.894B 0.00
Exelixis (EXEL) United States $11.167B 17.88
Avidity Biosciences (RNA) United States $10.668B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.514B 19.07
QIAGEN (QGEN) Netherlands $9.852B 18.70
Moderna (MRNA) United States $9.677B 0.00
Bio-Techne Corp (TECH) United States $9.252B 34.52
Abivax SA (ABVX) France $8.592B 0.00
Repligen (RGEN) United States $8.577B 91.79
Jazz Pharmaceuticals (JAZZ) Ireland $8.572B 33.43
Bio-Rad Laboratories (BIO.B) United States $8.481B 30.49
Halozyme Therapeutics (HALO) United States $8.235B 13.16
Cytokinetics (CYTK) United States $8.123B 0.00
Merus (MRUS) Netherlands $7.278B 0.00
Axsome Therapeutics (AXSM) United States $7.042B 0.00
Nuvalent (NUVL) United States $7.016B 0.00
Cidara Therapeutics (CDTX) United States $6.845B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.634B 0.00
Vaxcyte (PCVX) United States $6.374B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.231B 0.00
PTC Therapeutics (PTCT) United States $6.046B 8.21
Krystal Biotech (KRYS) United States $5.978B 30.91
Zealand Pharma (ZLDPF) Denmark $5.717B 5.79
Arrowhead Pharmaceuticals (ARWR) United States $5.705B 0.00
Legend Biotech (LEGN) United States $5.591B 0.00
Protagonist Therapeutics (PTGX) United States $5.289B 136.47
Arcellx (ACLX) United States $5.203B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.006B 0.00
TG Therapeutics (TGTX) United States $4.922B 11.15
Alkermes (ALKS) Ireland $4.795B 14.10
Cogent Biosciences (COGT) United States $4.775B 0.00
Kymera Therapeutics (KYMR) United States $4.672B 0.00
Praxis Precision Medicines (PRAX) United States $4.662B 0.00
Akero Therapeutics (AKRO) United States $4.466B 0.00
Viking Therapeutics (VKTX) United States $4.421B 0.00
Immunovant (IMVT) United States $4.161B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.064B 34.31
Ligand Pharmaceuticals (LGND) United States $3.953B 97.03
Celcuity (CELC) United States $3.932B 0.00
Anbio Biotechnology (NNNN) Germany $3.744B 0.00
Belite Bio (BLTE) United States $3.716B 0.00
ADMA Biologics Inc (ADMA) United States $3.703B 26.37
Mirum Pharmaceuticals (MIRM) United States $3.672B 0.00
Scholar Rock Holding (SRRK) United States $3.596B 0.00
Disc Medicine (IRON) United States $3.396B 0.00
Mineralys Therapeutics (MLYS) United States $3.233B 0.00
Ascentage Pharma Group - (AAPG) China $3.201B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.191B 0.00
Telix Pharmaceuticals (TLX) Australia $3.161B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.150B 0.00
CG Oncology (CGON) United States $3.127B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.095B 0.00
Travere Therapeutics (TVTX) United States $3.087B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.062B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.056B 89.60
Apogee Therapeutics (APGE) United States $3.020B 0.00
Amicus Therapeutics (FOLD) United States $2.925B 237.00
Jyong Biotech (MENS) Taiwan $2.904B 0.00
GRAIL (GRAL) United States $2.871B 0.00
IDEAYA Biosciences (IDYA) United States $2.818B 0.00
Viridian Therapeutics (VRDN) United States $2.746B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.630B 0.00
Apellis Pharmaceuticals (APLS) United States $2.572B 65.58
Denali Therapeutics (DNLI) United States $2.558B 0.00
Agios Pharmaceuticals (AGIO) United States $2.545B 0.00
Liquidia (LQDA) United States $2.439B 0.00
Zai Lab (ZLAB) China $2.431B 0.00
Edgewise Therapeutics (EWTX) United States $2.409B 0.00
Beam Therapeutics (BEAM) United States $2.204B 0.00
Arcus Biosciences (RCUS) United States $2.167B 0.00
Bavarian Nordic (BVNRY) Denmark $2.161B 5.86
Recursion Pharmaceuticals (RXRX) United States $2.155B 0.00
Adaptive Biotechnologies (ADPT) United States $2.153B 0.00
Structure Therapeutics (GPCR) United States $2.121B 0.00
ImmunityBio (IBRX) United States $2.049B 0.00
Terns Pharmaceuticals (TERN) United States $2.032B 0.00
Vericel (VCEL) United States $2.016B 166.08
Sarepta Therapeutics (SRPT) United States $1.971B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.960B 10.70
Mesoblast (MESO) Australia $1.895B 0.00
ANI Pharmaceuticals (ANIP) United States $1.888B 14.64
Zenas BioPharma (ZBIO) United States $1.879B 0.00
UniQure (QURE) Netherlands $1.861B 0.00
Spyre Therapeutics (SYRE) United States $1.823B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.811B 0.00
Vera Therapeutics (VERA) United States $1.809B 0.00
Janux Therapeutics (JANX) United States $1.761B 0.00
Dianthus Therapeutics (DNTH) United States $1.751B 0.00
Celldex Therapeutics (CLDX) United States $1.698B 0.00
Nuvation Bio (NUVB) United States $1.666B 0.00
Alvotech (ALVO) Luxembourg $1.655B 23.87
Sionna Therapeutics (SION) United States $1.651B 0.00
Twist Bioscience (TWST) United States $1.622B 0.00
Immunome (IMNM) United States $1.572B 0.00
Maze Therapeutics (MAZE) United States $1.565B 0.00
MannKind (MNKD) United States $1.554B 50.60
Stoke Therapeutics (STOK) United States $1.514B 39.57
Precigen (PGEN) United States $1.445B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.445B 0.00
Zymeworks (ZYME) United States $1.386B 0.00
Trevi Therapeutics (TRVI) United States $1.385B 0.00
NeoGenomics (NEO) United States $1.338B 0.00
Certara (CERT) United States $1.327B 24.50
Upstream Bio (UPB) United States $1.326B 0.00
Dynavax Technologies (DVAX) United States $1.299B 38.14
NovoCure (NVCR) Jersey $1.268B 0.00
Immatics (IMTX) Germany $1.240B 0.00
Pharvaris (PHVS) Netherlands $1.231B 0.00
Oric Pharmaceuticals (ORIC) United States $1.190B 0.00
CureVac (CVAC) Germany $1.185B 5.50
WAVE Life Sciences (WVE) Singapore $1.184B 0.00
Rapport Therapeutics (RAPP) United States $1.162B 0.00
Pharming Group (PHAR) Netherlands $1.152B 0.00
Inhibrx Biosciences (INBX) United States $1.146B 0.00
Novavax (NVAX) United States $1.133B 2.88
Mind Medicine (MindMed) (MNMD) United States $1.118B 0.00
MBX Biosciences (MBX) United States $1.113B 0.00
Urogen Pharma (URGN) United States $1.112B 0.00
AbCellera Biologics (ABCL) Canada $1.105B 0.00
Tango Therapeutics (TNGX) United States $1.100B 0.00
MiMedx (MDXG) United States $1.093B 19.42
Sana Biotechnology (SANA) United States $1.063B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $1.049B 0.00
Septerna (SEPN) United States $1.042B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.036B 0.00
Kodiak Sciences (KOD) United States $1.031B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Oculis Holding AG (OCS) Switzerland $1.027B 0.00
Pacira BioSciences (PCRX) United States $1.023B 11.71
Intellia Therapeutics (NTLA) United States $1.008B 0.00
Nanobiotix S.A - (NBTX) France $0.997B 0.00
Palvella Therapeutics (PVLA) United States $0.991B 0.00
Nurix Therapeutics (NRIX) United States $0.984B 0.00
Iovance Biotherapeutics (IOVA) United States $0.981B 0.00
Castle Biosciences (CSTL) United States $0.976B 133.80
Kura Oncology (KURA) United States $0.975B 0.00
Fortrea Holdings (FTRE) United States $0.962B 20.41
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.959B 0.00
AnaptysBio (ANAB) United States $0.936B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.935B 44.88
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Rezolute (RZLT) United States $0.915B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.904B 0.00
BGM Group (BGM) China $0.902B 0.00
CorMedix Inc (CRMD) United States $0.886B 8.20
Biohaven (BHVN) United States $0.879B 0.00
Arbutus Biopharma (ABUS) United States $0.866B 0.00
Compass Therapeutics (CMPX) United States $0.859B 0.00
ArriVent BioPharma (AVBP) United States $0.854B 0.00
Tyra Biosciences (TYRA) United States $0.840B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.820B 0.00
Bicara Therapeutics (BCAX) United States $0.810B 0.00
LENZ Therapeutics (LENZ) United States $0.801B 0.00
Rapt Therapeutics (RAPT) United States $0.799B 0.00
Vir Biotechnology (VIR) United States $0.783B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.770B 99.88
Erasca (ERAS) United States $0.732B 0.00
GH Research (GHRS) Ireland $0.728B 0.00
Astria Therapeutics (ATXS) United States $0.718B 0.00
Geron (GERN) United States $0.715B 0.00
Replimune (REPL) United States $0.705B 0.00
Cytek Biosciences (CTKB) United States $0.703B 0.00
Arvinas (ARVN) United States $0.679B 0.00
Ventyx Biosciences (VTYX) United States $0.660B 0.00
MeiraGTx Holdings (MGTX) United States $0.659B 0.00
CytomX Therapeutics (CTMX) United States $0.657B 9.70
Corvus Pharmaceuticals (CRVS) United States $0.655B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Gossamer Bio (GOSS) United States $0.627B 0.00
Myriad Genetics (MYGN) United States $0.625B 0.00
Prime Medicine (PRME) United States $0.608B 0.00
MapLight Therapeutics (MPLT) United States $0.584B 0.00
Opthea (OPT) Australia $0.583B 0.00
REGENXBIO (RGNX) United States $0.583B 0.00
Olema Pharmaceuticals (OLMA) United States $0.577B 0.00
Alumis (ALMS) United States $0.574B 0.00
Inventiva S.A (IVA) France $0.557B 0.00
Niagen Bioscience (NAGE) United States $0.548B 42.94
Invivyd (IVVD) United States $0.548B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Emergent Biosolutions (EBS) United States $0.531B 5.11
Keros Therapeutics (KROS) United States $0.526B 11.21
Cullinan Therapeutics (CGEM) United States $0.505B 0.00
Verastem (VSTM) United States $0.504B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.491B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.487B 0.00
Monopar Therapeutics (MNPR) United States $0.481B 0.00
NovaBridge Biosciences (NBP) United States $0.478B 0.00
Fulcrum Therapeutics (FULC) United States $0.468B 0.00
Eton Pharmaceuticals (ETON) United States $0.454B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.450B 0.00
DBV Technologies S.A (DBVT) France $0.448B 0.00
Neumora Therapeutics (NMRA) United States $0.443B 0.00
EnGene Holdings (ENGN) Canada $0.437B 0.00
Absci (ABSI) United States $0.424B 0.00
Design Therapeutics (DSGN) United States $0.420B 0.00
Bright Minds Biosciences (DRUG) United States $0.408B 0.00
XOMA Royalty (XOMA) United States $0.404B 0.00
Kamada (KMDA) Israel $0.402B 19.42
PureTech Health (PRTC) United States $0.391B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.377B 0.00
Alto Neuroscience (ANRO) United States $0.376B 0.00
Ocugen (OCGN) United States $0.372B 0.00
Northwest Biotherapeutics (NWBO) United States $0.370B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.365B 0.00
Jade Biosciences (JBIO) United States $0.349B 0.00
Tectonic Therapeutic (TECX) United States $0.347B 0.00
Benitec Biopharma (BNTC) United States $0.345B 0.00
Aura Biosciences (AURA) United States $0.344B 0.00
Amarin (AMRN) Ireland $0.340B 0.00
Entrada Therapeutics (TRDA) United States $0.334B 0.00
AC Immune (ACIU) Switzerland $0.330B 0.00
Solid Biosciences (SLDB) United States $0.330B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.330B 0.00
Neurogene (NGNE) United States $0.325B 0.00
Annexon (ANNX) United States $0.324B 0.00
X4 Pharmaceuticals (XFOR) United States $0.320B 0.00
Palisade Bio (PALI) United States $0.319B 0.00
Anavex Life Sciences (AVXL) United States $0.313B 0.00
Contineum Therapeutics (CTNM) United States $0.311B 0.00
DiaMedica Therapeutics (DMAC) United States $0.309B 0.00
Kyverna Therapeutics (KYTX) United States $0.301B 0.00
Lifecore Biomedical (LFCR) United States $0.298B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.283B 0.00
BioAge Labs (BIOA) United States $0.280B 0.00
Allogene Therapeutics (ALLO) United States $0.276B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Zura Bio (ZURA) United States $0.265B 0.00
Foghorn Therapeutics (FHTX) United States $0.265B 0.00
Immuneering (IMRX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.258B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.257B 0.00
Candel Therapeutics (CADL) United States $0.255B 0.00
Editas Medicine (EDIT) United States $0.254B 0.00
Sagimet Biosciences (SGMT) United States $0.252B 0.00
Puma Biotechnology (PBYI) United States $0.246B 6.61
Abeona Therapeutics (ABEO) United States $0.241B 3.94
C4 Therapeutics (CCCC) United States $0.239B 0.00
Alpha Teknova (TKNO) United States $0.238B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.236B 0.00
Atea Pharmaceuticals (AVIR) United States $0.231B 0.00
Black Diamond Therapeutics (BDTX) United States $0.228B 11.14
Rani Therapeutics Holdings (RANI) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.228B 0.00
Nautilus Biotechnology (NAUT) United States $0.227B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.222B 0.00
Cabaletta Bio (CABA) United States $0.222B 0.00
Tenaya Therapeutics (TNYA) United States $0.221B 0.00
Adherex Technologies (FENC) United States $0.221B 0.00
Voyager Therapeutics (VYGR) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
Aardvark Therapeutics (AARD) United States $0.215B 0.00
GENFIT S.A (GNFT) France $0.213B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.207B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.205B 0.00
Genelux (GNLX) United States $0.202B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.201B 0.00
Humacyte (HUMA) United States $0.195B 0.00
Cartesian Therapeutics (RNAC) United States $0.194B 0.00
CAMP4 Therapeutics (CAMP) United States $0.192B 0.00
Caribou Biosciences (CRBU) United States $0.186B 0.00
Crescent Biopharma (CBIO) United States $0.181B 0.00
SELLAS Life Sciences (SLS) United States $0.179B 0.00
Forte Biosciences (FBRX) United States $0.175B 0.00
Molecular Partners AG (MOLN) Switzerland $0.170B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.170B 0.00
MaxCyte (MXCT) United States $0.168B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
PepGen (PEPG) United States $0.155B 0.00
Nuvectis Pharma (NVCT) United States $0.154B 0.00
Seres Therapeutics (MCRB) United States $0.151B 0.00
Sangamo Therapeutics (SGMO) United States $0.150B 0.00
Codexis (CDXS) United States $0.149B 0.00
Agenus (AGEN) United States $0.148B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Elicio Therapeutics (ELTX) United States $0.146B 0.00
Anika Therapeutics (ANIK) United States $0.144B 0.00
Coherus Oncology (CHRS) United States $0.144B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
Immix Biopharma (IMMX) United States $0.141B 0.00
Mersana Therapeutics (MRSN) United States $0.139B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
Cognition Therapeutics (CGTX) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.137B 0.00
Spero Therapeutics (SPRO) United States $0.136B 0.00
Alector (ALEC) United States $0.135B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.135B 0.00
Scilex Holding (SCLX) United States $0.134B 0.00
Nkarta (NKTX) United States $0.133B 0.00
Opus Genetics (IRD) United States $0.130B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
EXoZymes (EXOZ) United States $0.128B 0.00
Alpha Cognition (ACOG) Canada $0.124B 0.00
Entera Bio (ENTX) Israel $0.124B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
VTv Therapeutics (VTVT) United States $0.121B 0.00
Shattuck Labs (STTK) United States $0.119B 0.00
BioHarvest Sciences (BHST) Canada $0.119B 0.00
Connect Biopharma Holdings (CNTB) United States $0.119B 0.00
VistaGen Therapeutics (VTGN) United States $0.117B 0.00
Greenwich LifeSciences (GLSI) United States $0.115B 0.00
Turn Therapeutics (TTRX) United States $0.112B 0.00
Seer (SEER) United States $0.112B 0.00
Fate Therapeutics (FATE) United States $0.111B 0.00
Starpharma Holdings (SPHRY) Australia $0.110B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.105B 0.00
TuHURA Biosciences (HURA) United States $0.105B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.105B 0.00
Citius Oncology (CTOR) United States $0.104B 0.00
Oncolytics Biotech (ONCY) Canada $0.104B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.104B 0.00
Pliant Therapeutics (PLRX) United States $0.103B 0.00
Kalaris Therapeutics (KLRS) United States $0.102B 0.00
Adicet Bio (ACET) United States $0.102B 0.00
Whitehawk Therapeutics (WHWK) United States $0.101B 0.00
Atara Biotherapeutics (ATRA) United States $0.099B 6.31
Instil Bio (TIL) United States $0.097B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.095B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.094B 0.00
Quince Therapeutics (QNCX) United States $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.093B 0.00
InflaRx (IFRX) Germany $0.091B 0.00
Biomea Fusion (BMEA) United States $0.091B 0.00
Chrome Holding (MEHCQ) United States $0.090B 0.00
Adagene (ADAG) China $0.086B 0.00
Clene (CLNN) United States $0.086B 0.00
Estrella Immunopharma (ESLA) United States $0.086B 0.00
OKYO Pharma (OKYO) $0.084B 0.00
BeyondSpring (BYSI) United States $0.084B 0.00
Tevogen Bio Holdings (TVGN) United States $0.082B 0.00
XBiotech (XBIT) United States $0.080B 0.00
Artiva Biotherapeutics (ARTV) United States $0.080B 0.00
Fortress Biotech (FBIO) United States $0.078B 0.00
Precision BioSciences (DTIL) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.077B 0.00
Immunic (IMUX) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.075B 0.00
ATyr Pharma (ATYR) United States $0.074B 0.00
CervoMed (CRVO) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.071B 0.00
Repare Therapeutics (RPTX) Canada $0.071B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.070B 0.00
Oncobiologics (OTLK) United States $0.070B 0.00
Vor Biopharma (VOR) $0.069B 0.00
BioStem Technologies (BSEM) $0.067B 4.68
TScan Therapeutics (TCRX) United States $0.062B 0.00
Annovis Bio (ANVS) United States $0.062B 0.00
Equillium (EQ) United States $0.062B 0.00
MiNK Therapeutics (INKT) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Spruce Biosciences (SPRB) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
BioAtla (BCAB) United States $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.043B 0.00
CalciMedica (CALC) United States $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.042B 0.00
Skye Bioscience (SKYE) United States $0.042B 0.00
Genenta Science S.p.A (GNTA) Italy $0.042B 0.00
Celularity (CELU) United States $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
Radiopharm Theranostics - (RADX) Australia $0.041B 0.00
TELA Bio (TELA) United States $0.040B 0.00
PDS Biotechnology (PDSB) United States $0.040B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
INmune Bio (INMB) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Generation Bio (GBIO) United States $0.037B 0.00
Galecto (GLTO) Denmark $0.036B 0.00
Hyperion DeFi (HYPD) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.032B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Elutia (ELUT) United States $0.032B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Applied Therapeutics (APLT) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Femasys (FEMY) United States $0.029B 0.00
Rein Therapeutics (RNTX) United States $0.029B 0.00
Passage Bio (PASG) United States $0.028B 0.00
Quantum Biopharma (QNTM) Canada $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Jasper Therapeutics (JSPR) United States $0.027B 0.00
Apollomics (APLM) United States $0.027B 0.00
Rallybio (RLYB) United States $0.027B 0.00
NextCure (NXTC) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Intensity Therapeutics (INTS) United States $0.026B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
IBio (IBIO) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
Exicure (XCUR) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Synaptogenix (TAOX) United States $0.023B 0.00
Tharimmune (THAR) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Clearside Biomedical (CLSD) United States $0.020B 0.00
Synlogic (SYBX) United States $0.020B 0.00
FibroBiologics (FBLG) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Athira Pharma (ATHA) United States $0.018B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.017B 0.00
Curis (CRIS) United States $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
MetaVia (MTVA) United States $0.017B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Longeveron (LGVN) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
GeoVax Labs (GOVX) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.011B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.010B 0.00
Acurx Pharmaceuticals (ACXP) $0.010B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Gelteq (GELS) Australia $0.009B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
GT Biopharma (GTBP) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.35
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00